Perle Bioscience, Inc. — Form D/A
Perle Bioscience, Inc. of CHARLESTON, SC, a company, filed a Form D amendment with the SEC on 2014-07-28. The offering totals $3.3M, of which $2.9M was reported sold. Industry: Other.
Offering
- Filed: 2014-07-28
- Form: D/A
- Accession: 0001605829-14-000004
- Industry: Other
- Exemptions: 06b
- Total offering: $3.3M
- Amount sold: $2.9M
- Remaining: $365K
- Investors: 14
- Date of first sale: 2014-04-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-216454
Issuer
- Name: Perle Bioscience, Inc.
- CIK: 0001605829
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 520 FOLLY ROAD, SUITE P212, CHARLESTON, SC, 29412
- Phone: 843-568-2603
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Lloyd A Pearson | Executive Officer | Greenville, NC |
| Ryan N Fiorini | Director | Charleston, SC |
| Ryan N Fiorini | Executive Officer | Charleston, SC |
| Jeffrey N Riley | Director | Charleston, SC |
| Douglas N Carnes | Director | Charleston, SC |
| Donna N Hill | Director | Charleston, SC |
| Claresa N Levetan | Director | Charleston, SC |
| Claresa N Levetan | Executive Officer | Charleston, SC |
| Gilbert N Nathan | Director | Charleston, SC |
Other filings by this issuer (4)
More